Tangent Medical (www.tangentmedical.com), an innovator in IV therapy products, announced the international launch of its NovaCath™ Integrated IV Catheter System in Canada after receiving clearance from the Health Canada organization. The NovaCath is a next-generation technology designed to address several complex IV therapy challenges including catheter stabilization, occupational exposure to blood, patient and healthcare worker safety and patient discomfort. It's the first safety IV catheter offering advanced catheter stabilization technology designed to exceed the highest CDC, OSHA, and INS standards for stabilization. Last month, Tangent Medical raised a $5 million senior secured term loan credit facility from GE Capital, Healthcare Financial Services to commercialize NovaCath in larger countries where healthcare worker safety legislation has been passed.
"Our focus for 2014 is to achieve clinical adoption of NovaCath at select hospitals in the U.S.," said Tangent Medical CEO Jeff Williams. "In addition, we will secure distribution agreements in key international markets to begin commercialization outside the U.S."
"The NovaCath Integrated IV Catheter System is a promising new IV catheter designed to advance the safety and welfare of both patients and healthcare workers," Curtis Bloch, Tangent's VP of Sales and Marketing, added. "It's designed to reduce overall IV complications including dislodgement, infiltration, phlebitis, and occlusion. Its passive needle shielding technology and closed system is designed to minimize occupational exposure to blood. We believe our patented design not only elevates safety, but adds a layer of comfort that has not been achievable with other IV catheters."
About Tangent Medical
Tangent Medical is focused on the development and commercialization of IV therapy products. Founded in 2009, the company's patented NovaCath™ Integrated IV Catheter System is the only safety IV catheter to cost-effectively integrate advanced catheter stabilization, passive needle encapsulation and blood control. Based on extensive clinical research into the needs of both healthcare workers and patients, this next-generation system is designed to establish a new standard in catheter design, functionality and performance. For more information, visitwww.tangentmedical.com.
Contact:
John Sperrazzo
Eye-To-Eye Communications, Inc.
john@eyetoeyepr.com
858-361-4495 (cell)
SOURCE: Tangent Medical Technologies, Inc.
Associated Documentation:
Link to submission on http://www.eteligis.com
Tangent_Medical_Technologies_3-21-2014_ELS_ETL.docx
To unsubscribe from any future mailings, please visit: http://www.eteligis.com/MassMailUnsubscribe.aspx
Copyright eTeligis Inc. 2014. All rights reserved.
0 comments:
Post a Comment